Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pravir Kumar

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
ACS Omega|March 8, 2021
Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer's and Parkinson's DiseaseRohan Gupta, Pravir Kumar
Neurochemistry International|March 25, 2022
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeuticsDivya Yadav, Pravir Kumar
Interdisciplinary Sciences, Computational Life Sciences|September 9, 2018
An In-Silico Investigation of Key Lysine Residues and Their Selection for Clearing off Aβ and Holo-AβPP Through UbiquitinationDhiraj Kumar, Pravir Kumar
ACS Omega|June 7, 2021
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics ApproachDia Advani, Pravir Kumar
Neuropeptides|September 22, 2019
Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptidesDhiraj Kumar, Pravir Kumar
Molecular Neurobiology|March 27, 2024
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed DrugsDia Advani, Pravir Kumar
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Integrated Mechanism of Lysine 351, PARK2, and STUB1 in AβPP UbiquitinationDhiraj Kumar, Pravir Kumar
Neuropeptides|August 22, 2022
Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachDia Advani, Pravir Kumar
ACS Omega|March 27, 2023
Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma MultiformeSmita Kumari, Pravir Kumar
Integrative Biology : Quantitative Biosciences From Nano to Macro|February 22, 2025
Identification of CXCR4 inhibitory activity in natural compounds using cheminformatics-guided machine learning algorithmsRahul Tripathi, Pravir Kumar
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
ACS Omega|March 8, 2021
Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer's and Parkinson's DiseaseRohan Gupta, Pravir Kumar
Neurochemistry International|March 25, 2022
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeuticsDivya Yadav, Pravir Kumar
Interdisciplinary Sciences, Computational Life Sciences|September 9, 2018
An In-Silico Investigation of Key Lysine Residues and Their Selection for Clearing off Aβ and Holo-AβPP Through UbiquitinationDhiraj Kumar, Pravir Kumar
ACS Omega|June 7, 2021
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics ApproachDia Advani, Pravir Kumar
Neuropeptides|September 22, 2019
Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptidesDhiraj Kumar, Pravir Kumar
Molecular Neurobiology|March 27, 2024
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed DrugsDia Advani, Pravir Kumar
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Integrated Mechanism of Lysine 351, PARK2, and STUB1 in AβPP UbiquitinationDhiraj Kumar, Pravir Kumar
Neuropeptides|August 22, 2022
Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachDia Advani, Pravir Kumar
ACS Omega|March 27, 2023
Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma MultiformeSmita Kumari, Pravir Kumar
Integrative Biology : Quantitative Biosciences From Nano to Macro|February 22, 2025
Identification of CXCR4 inhibitory activity in natural compounds using cheminformatics-guided machine learning algorithmsRahul Tripathi, Pravir Kumar
Pageof 10